Should we screen for colonization to control the spread of multidrug resistant bacteria?;Quelles stratégies découlent de la surveillance des bactéries multirésistantes aux antibiotiques afin de mieux maîtriser leur diffusion?

Pathologie Biologie

Volumn 51, Issue 8-9, 2003, Pages 464-468

  Lepelletier, D ^a   Perron, S ^a   Huguenin, H ^a   Picard, M ^a   Bemer, P ^a   Caillon, J ^a   Juvin, M E ^a   Drugeon, H ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Multidrug resistant bacteria; Preventive measures; Screening for colonization; Surveillance

Indexed keywords

ACINETOBACTER BAUMANNII; BACTERIAL COLONIZATION; CONFERENCE PAPER; ENTEROBACTERIACEAE; FRANCE; HYGIENE; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SCREENING; STAPHYLOCOCCUS AUREUS;

EID: 0142087544     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(03)00150-0     Document Type: Conference Paper

References (15)

1. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York city hospitals. Emerg Infect Dis 1999;5:9-17.
2. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1992;9:1065-78.
3. Gold HS, Moellering RC. Antimicrobial-drug resistance. N engl J Med 1996;335:1445-53.
4. Voss A, Milatovic D, Walhauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur Clin Microbiol Infect Dis 1994;13:50-5.
5. Maîtrise de la diffusion des bactéries multiré sistantes aux antibiotiques. Recommandations pour les établissements de soins. Comité technique national des infections nosocomiales. Ministère de l'emploi et de la solidarité; 1999.
6. Goldman DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in the hospitals: a challenge to hospital leadership. Jama 1996;275(3):234-40.
7. Garner JS. Guideline for isolation precautions. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:53-80.
8. Lepelletier D, Richet H. Surveillance and control of methicillin-resistant Staphylococcus aureus infections in French hospitals. Infect Control Hosp Epidemiol 2001;22:677-82.
9. Vincent JL, Bihari D, Suter P. The prevalence of nosocomial infection in intensive care units in Europe: results of the European prevalence of infection in intensive care unit (EPIC) study. Jama 1995;274:639-44.
10. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: result of a multicenter study. Arch Intern Med 2003;163(2):181-8.
11. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-50.
12. Shlaes DM, Gerding DN, John Jr JF, et al. Society of Healthcare Epidemiology and Infectious Diseases Society of America Joint committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18:275-91.
13. Mc Gowan Jr JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-48.
14. Lepelletier D, Caroff N, Reynaud A, Richet H. Escherichia coli: epidemiology and analysis of risk factors for infections caused by resistant strains. Clin Infect Dis 1999;29(3):548-52.
15. Monnet D, Lopez-Lozano JM, Campillos P, et al. Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfert function models. Clin Microbiol Infect 2001(Suppl 5):29-36.